412018-50-9

Basic information

• Product Name: 1-(2,6-dichloropyridin-3-yl)ethanone
• Synonyms: 1-(2,6-dichloropyridin-3-yl)ethanone;ETHANONE, 1-(2,6-DICHLORO-3-PYRIDINYL)-;3-Acetyl-2,6-dichloropyridine;1-(2,6-dichloropyridin-3-yl)ethan-1-one;1-(2,6-Dichloro-3-pyridyl)ethanone;1-(2,6-Dichloropyridin-3-yl)
• CAS NO: 412018-50-9
• Molecular Formula: C₇H₅Cl₂NO
• Molecular Weight: 190.029
• Mol File: 412018-50-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 286.732 °C at 760 mmHg
• Flash Point: 127.211 °C
• Appearance: /
• Density: 1.376 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -4.81±0.10(Predicted)
• CAS DataBase Reference: 1-(2,6-dichloropyridin-3-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,6-dichloropyridin-3-yl)ethanone(412018-50-9)
• EPA Substance Registry System: 1-(2,6-dichloropyridin-3-yl)ethanone(412018-50-9)

Safety Data

• Hazardous Substances Data: 412018-50-9(Hazardous Substances Data)

Usage

General Description

1-(2,6-Dichloropyridin-3-yl)ethanone is a chemical compound with the molecular formula C7H5Cl2NO. It is a yellow solid that is used as a building block for the synthesis of various pharmaceuticals and agrochemicals. 1-(2,6-Dichloropyridin-3-yl)ethanone is also known as 3-(2,6-dichloro-pyridin-3-yl)-propan-2-one and is widely used in the chemical industry for its reactivity and utility in organic synthesis. It is commonly used as an intermediate in the manufacture of drugs, dyes, and other fine chemicals. 1-(2,6-Dichloropyridin-3-yl)ethanone is a valuable compound in organic chemistry due to its versatile nature and wide range of applications.

Upstream product

• 58584-83-1 2,6-dichloronicotinoyl chloride 
• 873936-98-2 Ro 4808591 
• 75-16-1 methylmagnesium bromide 
• 917-64-6 methyl magnesium iodide 
• 38496-18-3 2,6-dichloropyridine-3-carboxylic acid 

Downstream Products

• 1372148-87-2 C₁₅H₉ClF₂N₂OS 
• 1372148-89-4 C₂₀H₁₅F₂N₃O₂S 
• 1372148-91-8 C₂₀H₁₅F₂N₃O₄S 
• 1372148-93-0 C₂₀H₁₅F₂N₃O₃ 
• 1372148-95-2 C₁₉H₁₂F₂N₆O₂ 
• 1372148-97-4 C₂₀H₁₂F₂N₄O₂ 
• 1372148-99-6 C₁₉H₁₃F₂N₃O₃ 
• 1372149-01-3 C₂₁H₁₇F₂N₃O₂ 
• 1372148-86-1 C₁₅H₁₀Cl₂F₂N₂OS 
• 1375708-67-0 1-(2,6-dichloro-pyridin-3-yl)-ethanol 
• 1315179-60-2 1-(5-amino-2, 4-difluorophenyl)-7-(3, 5-dimethylisoxazol-4-yl)-2-methyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine 
• 1315179-68-0 1-(5-amino-2, 3, 4-trifluorophenyl)-7-(3, 5-dimethylisoxazol-4-yl)-2-methyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine 
• 1315179-96-4 1-(5-tert-butoxycarbonylamino-2, 4-difluorophenyl)-7-chloro-2-methyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine 
• 1315180-05-2 1-(5-tert-butoxycarbonylamino-2, 3, 4-trifluorophenyl)-7-chloro-2-methyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine 

Relevant articles and documents

INDAZOLE AND AZAINDAZOLE COMPOUNDS AS IRAK-4 INHIBITORS

The present invention provides indazole and aza indazole compounds of formula (I) or (II) and pharmaceutically acceptable salts thereof, and their use to inhibit IRAK-4 and/or for the treatment of diseases or disorders induced by IRAK-4.

DIFLUOROMETHYLENE COMPOUND

The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.

Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases

The present invention relates to novel compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compounds, processes for making said compounds, and their use as medicaments for treatment and/or prevention of Aβ-related diseases.